MX2012000893A - Metodo para formar particulas de cefquinoma. - Google Patents

Metodo para formar particulas de cefquinoma.

Info

Publication number
MX2012000893A
MX2012000893A MX2012000893A MX2012000893A MX2012000893A MX 2012000893 A MX2012000893 A MX 2012000893A MX 2012000893 A MX2012000893 A MX 2012000893A MX 2012000893 A MX2012000893 A MX 2012000893A MX 2012000893 A MX2012000893 A MX 2012000893A
Authority
MX
Mexico
Prior art keywords
cefquinome
particles
acid
addition salt
sulfate
Prior art date
Application number
MX2012000893A
Other languages
English (en)
Inventor
Hans Peter Niedermann
Heiko Bothe
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2012000893A publication Critical patent/MX2012000893A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe un procedimiento para la producción de partículas de una sal de adición ácida de cefquinoma, preferiblemente partículas de sulfato de cefquinoma, por precipitación de la sal de adición ácida de cefquinoma, preferiblemente el sulfato, de una solución de betaína de cefquinoma, en donde ácido, preferiblemente ácido sulfúrico, es añadido a la solución de betaína; de acuerdo con la invención el ácido, preferiblemente ácido sulfúrico, es agregado rápidamente en una sola aplicación, en un exceso molar de 40% a menos de 100%; como resultado, se forman partículas que comprenden aglomerados de partículas cristalinas primarias de microescala; esto permite proporcionar partículas de sal de adición ácida de cefquinoma, preferiblemente sulfato de cefquinoma, en tamaños de partículas conmensurados con material micronizado, pero con estabilidad mejorada.
MX2012000893A 2009-07-20 2010-07-19 Metodo para formar particulas de cefquinoma. MX2012000893A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09165895 2009-07-20
US22719509P 2009-07-21 2009-07-21
PCT/EP2010/060376 WO2011009827A1 (en) 2009-07-20 2010-07-19 Method of making cefquinome particles

Publications (1)

Publication Number Publication Date
MX2012000893A true MX2012000893A (es) 2012-02-28

Family

ID=41217555

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000893A MX2012000893A (es) 2009-07-20 2010-07-19 Metodo para formar particulas de cefquinoma.

Country Status (15)

Country Link
US (1) US20120122832A1 (es)
EP (1) EP2456775B1 (es)
JP (2) JP5859436B2 (es)
CN (1) CN102471350B (es)
AR (1) AR077320A1 (es)
AU (1) AU2010275302B2 (es)
BR (1) BR112012001233B1 (es)
CA (1) CA2768088A1 (es)
ES (1) ES2432240T3 (es)
IN (1) IN2012DN00227A (es)
MX (1) MX2012000893A (es)
PL (1) PL2456775T3 (es)
SG (1) SG177728A1 (es)
TW (1) TWI400243B (es)
WO (1) WO2011009827A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾(cefquinome)粒子的方法
CN114869850B (zh) * 2022-06-20 2023-04-28 山东晟阳生物工程有限公司 硫酸头孢喹肟注射液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt
DE3706020A1 (de) 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
BR0013754A (pt) 1999-09-03 2002-05-21 Janssen Pharmaceutica Nv Formulação veterinaria para administração de uma droga insolúvel em água a um animal alvo através de um sistema de distribuição de água
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle
JP4584715B2 (ja) * 2002-10-25 2010-11-24 インターベツト・インターナシヨナル・ベー・ベー 持続放出性医薬組成物
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
ITMI20042139A1 (it) 2004-11-08 2005-02-08 Acs Dobfar Spa Procedimento per la produzione di cefepime e cefaposporine analoghe
PT1945223E (pt) * 2005-10-29 2010-10-14 Intervet Int Bv Composições de cefquinoma e métodos para a sua utilização
CN101050220A (zh) * 2007-05-21 2007-10-10 蒋春茂 一种动物抗生素硫酸头孢喹肟的制备方法
CN101536985A (zh) * 2008-03-17 2009-09-23 天津瑞普生物技术集团有限公司 一种畜禽使用的头孢喹肟肺靶向微球及其制备方法
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾(cefquinome)粒子的方法

Also Published As

Publication number Publication date
IN2012DN00227A (es) 2015-05-01
PL2456775T3 (pl) 2014-01-31
AU2010275302A1 (en) 2012-02-02
EP2456775A1 (en) 2012-05-30
JP2016047827A (ja) 2016-04-07
SG177728A1 (en) 2012-02-28
US20120122832A1 (en) 2012-05-17
TWI400243B (zh) 2013-07-01
EP2456775B1 (en) 2013-08-21
AR077320A1 (es) 2011-08-17
TW201116538A (en) 2011-05-16
CN102471350A (zh) 2012-05-23
CA2768088A1 (en) 2011-01-27
ES2432240T3 (es) 2013-12-02
JP5859436B2 (ja) 2016-02-10
CN102471350B (zh) 2015-05-06
BR112012001233B1 (pt) 2019-06-11
AU2010275302B2 (en) 2014-10-09
JP6346144B2 (ja) 2018-06-20
WO2011009827A1 (en) 2011-01-27
BR112012001233A2 (pt) 2016-03-08
JP2012533596A (ja) 2012-12-27

Similar Documents

Publication Publication Date Title
JO3218B1 (ar) إنتاج كربونات كالسيوم مترسبة عالية النقاوة
MX346652B (es) Carbonato de calcio precipitado de desecho de la molienda de pulpa que tiene brillo mejorado y metodo para su produccion y uso.
MY191236A (en) Diorganylphosphinic acid salts, method for the production thereof and the use thereof
MY162811A (en) Food containing milk ceramide, and process for production thereof
WO2016050232A3 (de) Verfahren zur herstellung von kaliumsulfat-granulaten und das hieraus erhaltene kaliumsulfat-granulat sowie dessen verwendung
JP2014523491A5 (es)
WO2012013454A8 (de) Verfahren zur verminderung von magnetischen und/oder oxidischen verunreinigungen in lithium-metall-sauerstoff-verbindungen
EP2431374A4 (en) PROCESS FOR THE PRODUCTION OF FINE PARTICLES OF PHOSPHONIC ACID METAL SALT
MX2013010089A (es) Produccion de acido carboxilico y co-productos de sal.
EP2796411A8 (en) Method for producing magnesium oxide
TN2015000372A1 (en) A method for concentrating rare-earth metals in phosphogypsum
MY185172A (en) Gypsum-based building products and method for the manufacture thereof
NZ705218A (en) Production of soluble protein products from hemp (”h701”)
MX2012013610A (es) Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina.
WO2015088625A3 (en) Compounds and methods of promoting myelination
MX2012000893A (es) Metodo para formar particulas de cefquinoma.
IL229664A (en) METHOD FOR PRODUCING DIHYDRATE / HYDHYDRATE PHARMACEUTICAL ACID
MY189848A (en) Microsilica slurry and method for producing such slurry
UA103913C2 (uk) Мікроелементна добавка до кормових сумішей для тварин і птахів в біодоступній формі
MX2011009262A (es) Produccion de suspensiones de alta pureza que contienen silices precipitadas por electrodialisis.
CA2797442A1 (en) Process for the production of ferrous sulphate monohydrate
MX2019002738A (es) Procedimiento para producir sulfato de potasio a partir de cloruro de potasio y acido sulfurico.
WO2009037901A1 (ja) 粉体化粧料およびこれに用いる平板状硫酸カルシウム2水塩の製造方法
MX2009011100A (es) Metodo para complementar una composicion liquida acuosa comestible con dos o mas sales minerales.
IN2015DN02241A (es)

Legal Events

Date Code Title Description
FG Grant or registration